Show simple item record

dc.contributor.authorSpecka, Michael
dc.contributor.authorBonnet, Udo
dc.contributor.authorHeilmann, Martin
dc.contributor.authorSchifano, Fabrizio
dc.contributor.authorScherbaum, Norbert
dc.date.accessioned2011-10-10T10:01:06Z
dc.date.available2011-10-10T10:01:06Z
dc.date.issued2011-08
dc.identifier.citationSpecka , M , Bonnet , U , Heilmann , M , Schifano , F & Scherbaum , N 2011 , ' Longitudinal patterns of benzodiazepine consumption in a German cohort of methadone maintenance treatment patients ' , Human Psychopharmacology: Clinical and Experimental , vol. 26 , no. 6 , pp. 404-411 . https://doi.org/10.1002/hup.1222
dc.identifier.issn0885-6222
dc.identifier.otherPURE: 406387
dc.identifier.otherPURE UUID: 0fbd1186-d826-418c-917e-427013745de2
dc.identifier.otherWOS: 000295005600006
dc.identifier.otherScopus: 80052260412
dc.identifier.urihttp://hdl.handle.net/2299/6615
dc.descriptionThe definitive version can be found at: http://onlinelibrary.wiley.com/ Copyright John Wiley & Sons [Full text of this article is not available in the UHRA]
dc.description.abstractObjective: Cross-sectional studies show that considerable proportions of opiate dependents in methadone maintenance treatment (MMT) consume benzodiazepines (BZD). The longitudinal patterns of BZD use over time were described here. Methods: After admission to MMT, patients from two outpatient MMT clinics (n=345) were observed for up to 2years whilst in treatment. The use of BZD, cannabis, opiates and cocaine was assessed by urine sampling carried out twice a month. Results: For the whole sample, the mean BZD-positive urine specimen rate was 0.36 during the first 3months. Rates slightly decreased during the first year and remained stable afterwards (last observation carried forward). For study completers (n=152), the rate decreased over time, from 0.31 (first 3-month period) to 0.19 (last period; p < 0.001). According to a longitudinal cluster analysis, 26% of all patients showed a pattern of constantly high BZD-positivity rates, mostly in combination with other substances. Inpatient detoxifications from BZD (carried out in 18% of cases) did not have a sustained effect on levels of BZD use. Conclusions: BZD consumption in MMT is often part of a polydrug consumption pattern and is associated with poorer treatment retention. It is necessary to further investigate the reasons for BZD use in MMT patients and to develop effective interventions to reduce levels of BZD consumption.en
dc.format.extent8
dc.language.isoeng
dc.relation.ispartofHuman Psychopharmacology: Clinical and Experimental
dc.subjectmethadone
dc.subjectbenzodiazepine
dc.subjectdrug misuse
dc.titleLongitudinal patterns of benzodiazepine consumption in a German cohort of methadone maintenance treatment patientsen
dc.contributor.institutionDepartment of Pharmacy
dc.contributor.institutionHealth & Human Sciences Research Institute
dc.description.statusPeer reviewed
rioxxterms.versionofrecordhttps://doi.org/10.1002/hup.1222
rioxxterms.typeJournal Article/Review
herts.preservation.rarelyaccessedtrue


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record